Background

Dr. John R. Laird, MD, FACC, FACP serves as Scientific Advisor of Morph Access Innovations at BioCardia, Inc. Dr. Laird serves as Advisor of NexGen Medical Systems, Inc. He serves as the Medical Director/Director of the Clinical Vascular Program at the University of California, Davis Medical Center, specializing in cardiovascular medicine, internal medicine, interventional cardiology, vascular and endovascular care and cardiology. He served as Scientific Advisor of CryoVascular ... Systems Inc. He served as Director of Peripheral Vascular Interventions at the Cardiovascular Research Institute and a Co-Director of the Center for Vascular Care at the Washington Hospital Center. He serves as a Member of Scientific Advisory Board of AngioSlide Ltd., and Member of Advisory Board of Genesis Medical Interventional Inc. He serves as a Member of the Medical Advisory Board at AngioScore, Inc. and Syntervention, Inc. He is a Founding Board Member of the VIVA Conference. He is Professor of Medicine at the University of California, Davis Medical Center. He was Principal Investigator for several important clinical trials and has lectured and performed internationally on a variety of topics related to endovascular interventions. He has published extensively on aneurysmal disease, renal artery disease, and peripheral artery disease. He is an internationally renowned Interventional Cardiologist. Dr. Laird is known for innovation, teaching vascular interventions to other physicians. Dr. Laird is a leader in the field of peripheral vascular intervention. His practice focuses on interventions for carotid artery disease, abdominal and thoracic aortic aneurysms.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.